Outcome of the Board Meeting held on Tuesday, May 05, 2026 for conversion of 111000 warrants into 111000 equity shares of face value of Rs. 10/-
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shelter Pharma's board approved conversion of 111,000 warrants held by non-promoter investor Rishabh Nayanbhai Sharma into 111,000 equity shares of Rs. 10 face value each. The conversion price of Rs. 31.6875 per share represents the remaining 75% of the original warrant issue price of Rs. 42.25, generating Rs. 35.17 lakh for the company. The share capital increased from Rs. 16.72 crore (16.72 million shares) to Rs. 16.83 crore (16.83 million shares). This is a partial conversion, with 129,000 warrants still outstanding for future conversion. The newly allotted shares will rank pari-passu with existing shares.
Minor dilution of approximately 0.66% to the existing shareholding. The conversion brings fresh capital of Rs. 35.17 lakh without additional debt burden, though remaining unconverted warrants could lead to further dilution.